266 related articles for article (PubMed ID: 26983806)
1. Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion.
Mavrommati I; Cisse O; Falasca M; Maffucci T
Sci Rep; 2016 Mar; 6():23277. PubMed ID: 26983806
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
Qiao M; Shapiro P; Kumar R; Passaniti A
J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
[TBL] [Abstract][Full Text] [Related]
3. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
[TBL] [Abstract][Full Text] [Related]
4. The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation.
Harada K; Truong AB; Cai T; Khavari PA
Mol Cell Biol; 2005 Dec; 25(24):11122-30. PubMed ID: 16314532
[TBL] [Abstract][Full Text] [Related]
5. Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.
Chikh A; Ferro R; Abbott JJ; Piñeiro R; Buus R; Iezzi M; Ricci F; Bergamaschi D; Ostano P; Chiorino G; Lattanzio R; Broggini M; Piantelli M; Maffucci T; Falasca M
Oncotarget; 2016 Apr; 7(14):18325-45. PubMed ID: 26934321
[TBL] [Abstract][Full Text] [Related]
6. The class II phosphoinositide 3-kinases PI3K-C2α and PI3K-C2β differentially regulate clathrin-dependent pinocytosis in human vascular endothelial cells.
Aung KT; Yoshioka K; Aki S; Ishimaru K; Takuwa N; Takuwa Y
J Physiol Sci; 2019 Mar; 69(2):263-280. PubMed ID: 30374841
[TBL] [Abstract][Full Text] [Related]
7. Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase C2beta-AKT pathway.
Das M; Scappini E; Martin NP; Wong KA; Dunn S; Chen YJ; Miller SL; Domin J; O'Bryan JP
Mol Cell Biol; 2007 Nov; 27(22):7906-17. PubMed ID: 17875942
[TBL] [Abstract][Full Text] [Related]
8. PI3K-C2β limits mTORC1 signaling and angiogenic growth.
Kobialka P; Llena J; Deleyto-Seldas N; Munar-Gelabert M; Dengra JA; Villacampa P; Albinyà-Pedrós A; Muixi L; Andrade J; van Splunder H; Angulo-Urarte A; Potente M; Grego-Bessa J; Castillo SD; Vanhaesebroeck B; Efeyan A; Graupera M
Sci Signal; 2023 Nov; 16(813):eadg1913. PubMed ID: 38015911
[TBL] [Abstract][Full Text] [Related]
9. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
Guenther MK; Graab U; Fulda S
Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
[TBL] [Abstract][Full Text] [Related]
10. Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis.
Tibolla G; Piñeiro R; Chiozzotto D; Mavrommati I; Wheeler AP; Norata GD; Catapano AL; Maffucci T; Falasca M
PLoS One; 2013; 8(1):e53808. PubMed ID: 23320105
[TBL] [Abstract][Full Text] [Related]
11. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
12. Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration.
Maffucci T; Cooke FT; Foster FM; Traer CJ; Fry MJ; Falasca M
J Cell Biol; 2005 Jun; 169(5):789-99. PubMed ID: 15928202
[TBL] [Abstract][Full Text] [Related]
13. Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration.
Tsai HR; Yang LM; Tsai WJ; Chiou WF
Eur J Pharmacol; 2004 Sep; 498(1-3):45-52. PubMed ID: 15363974
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY-142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines.
Balmanno K; Chell SD; Gillings AS; Hayat S; Cook SJ
Int J Cancer; 2009 Nov; 125(10):2332-41. PubMed ID: 19637312
[TBL] [Abstract][Full Text] [Related]
15. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
16. PKCδ-dependent activation of ERK1/2 leads to upregulation of the human NHE2 transcriptional activity in intestinal epithelial cell line C2BBe1.
Muthusamy S; Shukla S; Amin MR; Cheng M; Orenuga T; Dudeja PK; Malakooti J
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G317-25. PubMed ID: 22052014
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 8 induced downregulation of thrombospondin 1 is mediated by the MEK/ERK and PI3K pathways in breast cancer cells.
Tarkkonen K; Ruohola J; Härkönen P
Growth Factors; 2010 Aug; 28(4):256-67. PubMed ID: 20370578
[TBL] [Abstract][Full Text] [Related]
18. PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17beta-estradiol and growth factors.
Gentilini D; Busacca M; Di Francesco S; Vignali M; Viganò P; Di Blasio AM
Mol Hum Reprod; 2007 May; 13(5):317-22. PubMed ID: 17350964
[TBL] [Abstract][Full Text] [Related]
19. Class II PI3Ks α and β Are Required for Rho-Dependent Uterine Smooth Muscle Contraction and Parturition in Mice.
Sarker MAK; Aki S; Yoshioka K; Kuno K; Okamoto Y; Ishimaru K; Takuwa N; Takuwa Y
Endocrinology; 2019 Jan; 160(1):235-248. PubMed ID: 30476019
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.
Yang S; Ji M; Zhang L; Chen Y; Wennmann DO; Kremerskothen J; Dong J
Cell Signal; 2014 Feb; 26(2):343-51. PubMed ID: 24269383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
